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Abstract
Protein glycosylation alteration is typically employed by various viruses for escaping immune pressures from their hosts. Our
previous work had shown that not only the increase of glycosylation sites (glycosites) numbers, but also glycosite migration
might be involved in the evolution of human seasonal influenza H1N1 viruses. More importantly, glycosite migration was
likely a more effectively alteration way for the host adaption of human influenza H1N1 viruses. In this study, we provided
more bioinformatics and statistic evidences for further predicting the significant biological functions of glycosite migration
in the host adaptation of human influenza H1N1 viruses, by employing homology modeling and in silico protein
glycosylation of representative HA and NA proteins as well as amino acid variability analysis at antigenic sites of HA and NA.
The results showed that glycosite migrations in human influenza viruses have at least five possible functions: to more
effectively mask the antigenic sites, to more effectively protect the enzymatic cleavage sites of neuraminidase (NA), to
stabilize the polymeric structures, to regulate the receptor binding and catalytic activities and to balance the binding
activity of hemagglutinin (HA) with the release activity of NA. The information here can provide some constructive
suggestions for the function research related to protein glycosylation of influenza viruses, although these predictions still
need to be supported by experimental data.
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Introduction
Influenza virus can cause occasional pandemics and seasonal
epidemics in humans [1]. At the beginning of an influenza
pandemic, preexisting immunity to the newly emerging virus is
generally low in humans; thus, the virus can easily transfer from
one person to another and rapidly spread across the globe. Later,
on the one hand, immune antibodies to the virus are gradually
induced in the host, decreasing the virulence and transmissibility
of the virus. While on the other hand, the pandemic virus
undergoes gradual changes in its antigenic structure (called
antigenic drift) so as to escape the immune pressure imposed by
the host. Such pressure and drift lead to the transformation of the
pandemic virus to a seasonal one as well as the subsequent
evolution of the seasonal influenza virus [1,2,3,4].
Protein glycosylation is believed to be involved in the evolution
of influenza viruses [5,6]. Variation in protein glycosylation is a
more efficient mechanism than even the direct mutation of amino
acids for the virus to escape the surveillance of the host immune
system because the glycans themselves are host-derived and hence
considered as ‘‘self’’ by the immune system [7]. The HA and NA
glycosylation of an influenza strain can affect its host specificity,
virulence and infectivity either directly, by changing the biologic
properties of HA and NA [8], or indirectly, by attenuating
receptor binding [9,10,11,12,13], masking antigenic regions of the
protein [14,15,16], impeding the activation of the protein
precursor HA0 via its cleavage into the disulfide-linked subunits
HA1 and HA2 [17,18,19], regulating catalytic activity or
preventing proteolytic cleavage of the stalk of NA [20,21,22].
Previous reports showed that the seasonal H1N1 viruses
possessed more N-glycosylation sequons in their HA sequences
than the 1918 H1N1 strain (A/South Carolina/1/18) and it
played an important roles in the host adaptation of the viruses
[5,6,23]. Using a sequence-driven approach, Zhang et al. [6] found
that the number of potential glycosylation sites (glycosites) in
human H1N1 viruses oscillates between five and nine sites. Using
a similar genome-based method, Wei et al. [5] indicated that there
were more glycosites on the head of HA in human seasonal
influenza H1N1 viruses than that in human pandemic H1N1
viruses. In addition, they proved that two highly conserved
glycosites (Asn 142 and Asn 177) acquired in the RBD-A region of
HA in the seasonal strains (represented by A/New Caledonia/20/
1999) endow the seasonal virus with resistance to antibodies
directed against both of the pandemic strains from 1918 and 2009.
Das et al. [24] reported that the number of glycosylation sites in the
HA globular domain could focus sequence variation on those
regions unshielded by glycosylation. Wu et al. [22] also showed that
the distinct N-glycan profiles of NA from the 1918 pandemic
influenza virus might cause viral resistance to proteinase digestion
as well as high infectivity. In our previous work, by using a series of
bioinformatics tools, we found that increase of glycosite numbers
was mainly occurred in the early evolutionary stages of human
seasonal influenza A/H1N1 viruses, while glycosite migration
(location alteration of glycosites) became the dominating mode in
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e32119the later evolutionary stages. Importantly, we elucidated that the
positional conversion of glycosites might be a more effective mode
of glycosite alteration for the evolution of influenza A/H1N1
viruses, by analyzing the speed of a new mutant strain overtakes its
original one [25].
In this study, we provided more bioinformatics and statistic data
to further predict the significant biological functions of glycosite
migration in the host adaption of human influenza H1N1 viruses.
Several possible biological functions of glycosite migration in
human H1N1 viruses were summarized in this paper. These
predictions still needs to be supported by experimental data, the
information here can provide some constructive suggestions for the
research related to the functions of protein glycosylation in
influenza viruses.
Materials and Methods
Protein sequence data and 3D structure of HA and NA
from influenza A/H1N1 viruses
Full-length amino acid sequences of HA and NA from human
seasonal influenza A (H1N1) viruses were downloaded from the
influenza virus resource at the national center for biotechnology
information (NCBI) (http://www.ncbi.nlm.nih.gov/genomes/
FLU) [26,27] as of March 30, 2010. The crystal structure of A/
puerto rico/8/1934 HA (PDB code: 1RU7), A/California/04/
2009 HA (PDB code: 3LZG) and an influenza A (H5N1) NA (PDB
code: 2hty) were downloaded from PDB database (http://www.
rcsb.org).
Prediction of potential N-glycosylation sites and statistic
analysis of amino acid variability
Sequon Finder was used to predict N-glycosylation sites on HA
and NA. Sequon Finder is a custom-made program that just
simply finds all sequons (N-X-S/T, where X is not P) within
protein sequences and supposes all of sequons as potential
glycosylation sites [25]. The locations of the glycosylation sites
on HA and NA were numbered according to the full- length HA
sequence of South Carolina/1/1918 and the full-length NA
sequence of Brevig Mission/1/1918, respectively. The program is
available upon request.
Amino acid variability at each position of HA and NA was
quantified by counting the number of different amino acids found
at the position. If a position where all sequences in a group have
the same amino acid, the value of variability is set as 0. While for
example a variability value of 3 corresponds to a position that has
4 different possible amino acids. The amino acid variability at
each antigenic site was quantified by summing up the numbers of
variability at all locations in this antigenic site. The conversation of
tryptic cleavage sites in the stalk region of NA at each time period
were obtained by calculating the percentage of Lysine and
Arginine appeared at each site.
Homology modeling, in silico protein glycosylation and
visualization
The 3D structures of representative HA and NA proteins with
different patterns of potential N-glycosites in human seasonal
influenza A (H1N1) viruses were generated using SWISS-
MODEL (http://swissmodel.expasy.org/) [28]. The crystal struc-
ture of A/puerto rico/8/1934 HA (1RU7) and A/California/04/
2009 HA (3LZG) were used as the HA models of the human
influenza H1N1 viruses before and after 2000, respectively. An
influenza A (H5N1) NA (2hty) was used as the NA model. After
homology modeling, glycans were added onto the potential N-
glycosites of HA and NA using the Glyprot Server (http://www.
glycosciences.de/modeling/glyprot/) [29]. Complex glycan struc-
tures were selected for all accessible sites, and the terminal sialic
acid residues were manually removed in order to model the
natural state of the viral glycans. All of the figures were generated
and rendered using MacPyMOL [30].
Results
Glycosite migrations on the top of the HA head
Glycosite 179, appearing on the top of the HA head in human
influenza H1N1 viruses in 1933, was replaced by glycosite 177 in
1951 (Figure S1) [25]. Our modeling results indicated that the
glycans on glycosites 179 and 177 may not only shield the Sa site
of the same subunit (since both glycosites locate at the Sa site), but
also part of the antigenic sites Ca2 and Sb on the adjacent subunit
as well, respectively (Figure 1). However, glycosite 179 may also
Figure 1. Structural overviews of the glycans attached to glycosites 179 (A) and 177(B) and their shielding regions on HA of human
seasonal influenza H1N1 viruses. The glycosites are numbered in white.
doi:10.1371/journal.pone.0032119.g001
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adjacent subunit and the host receptor (Figure 1a). This may be
one of the reasons that glycosite 179 was replaced by glycosite 177
in 1951. The variability analysis on antigenic sites of HA also
showed that the amino acid variations decreased at the antigenic
site Sb but increased at the antigenic site Ca2 after 1951, which
supported the modeling results to a certain degree (Figure 2a).
Glycosite 144 appeared on the top of the HA head in human
influenza H1N1 viruses in 1940 and was replaced by glycosite 172
in 1947 (Figure S1) [25]. Then, the acquisition of glycosite 142 in
1986 may have rendered glycosite 172 unnecessary because
glycosite 172 ultimately disappeared in 1987. The glycans at
glycosites 142 may shield the antigenic site Sa more effectively
because it is located at the center Sa, while glycosites 172 is at the
edge of the antigenic site and glycosite 144 is adjacent to Sa
(Figure 3). That should also be one of the important reasons why
the amino acid variations of HA at Sa site after 1940 continuously
decreased till 1985(Figure 2a).
The glycosite migrations between different regions may
collaborate with each other. For example, the glycans at glycosite
144 may be better in shielding antigenic site Sb than glycans at
glycosites 172 and 142, but since glycans at glycosite 177 on the
adjacent subunit can shield this antigenic site well, the glycosite
142 become more preponderant than glycosite 144 as it is better in
protecting antigenic Sa site. In fact, these glycosite migrations may
result in totally different antigenic activity for influenza H1N1
viruses. Previous reports had shown that there was no cross-
protection existed between H1 vaccines produced before and after
1986 (Table S1) [31]. Our analysis revealed that this might be due
to the glycosites migrations from site 172 (and/or 144) to site 142
and/or from sites 286 and 104 to site 71, because all three vaccine
strains before 1986 had the same glycosite patterns (without
glycosites 71 and 142) on HA, but glycosites 172 (and/or 144) and
286 (and/or 104) had been replaced by glycosites 142 and 71 since
1986, respectively (Table S2). Besides, glycosite 365 was also
replaced by glycosite 434 in 1986 which might also have some
effects on the cross-protection of vaccines (see below and Table
S3).
Glycosite migrations on the side of the HA head
Region B belongs to the vestigial esterase domain which may
have played a role as a fusion protein that inserted the virus into an
ancestral membrane before giving rise to the modern version of
HA [32]. In this region, glycosites 286 and 104 had existed since
1933 and 1940, respectively (Figure S1) [25]. The glycans on
glycosite 104 can effectively shield Ca2 and part of the antigenic
site Ca1 on the adjacent subunit, but it may also shield part of the
receptor binding site (Figure 4a). The glycans on glycosite 286 may
predominately shield a region below this site (Figure 4b). However,
the glycans on glycosite 71 can shield glycosites 104 and 286 as
well as part of Ca2 (Figure 4c). Thus, glycosite 71 might be highly
advantageous for the prevalence of influenza viruses in humans
thereby making glycosylation at glycosites 104 and 286 unneces-
sary. Besides, we speculated that the glycosite migrations in this
region may also have some positive effects on the membrane
fusion activity of human seasonal influenza H1N1 virus.
Glycosite migrations on the head of NA
Among four glycosites (glycosites 146, 365, 434 and 455) on the
head of each NA monomer in human seasonal influenza H1N1
viruses, three of them (except glycosite 455) were located around
the enzymatic active site (Figure 5a). The glycan attached to
glycosite 146 could effectively shield antigenic site 1 and antigenic
site 6 of the neighboring subunit of the tetrameric NA (Figure 5b).
This shielding might be necessary for the function of NA and for
the survival of the virus because glycosite 146 was highly conserved
in almost all strains regardless of the host, and it might also be one
of the important reasons that why the amino acid variations at
antigenic sites 1 and 6 were very low in the evolution of human
influenza viruses (Figure 2b). Glycosite 365, appearing on the head
of NA in 1936, was replaced by glycosite 434 in 1986–1987
(Figure S1) [25]. Glycosites 365 and 434 are located at antigenic
sites 5 and 7, respectively. The glycan attached to glycosite 365
could shield antigenic sites 3 and 5 (Figure 5c), while the glycan
attached to glycosite 434 could only shield part of antigenic site 7
(Figure 5d). But glycosite 434, like glycosites 146 and 455, is at the
subunit interface. The glycans at these glycosites could effectively
shield the domain that joins two subunits and thus may stabilize
the NA tetramer (Figure 5a). Therefore, the stability of the NA
tetramer may also be very important, perhaps occasionally even
more important than the resistance of NA to antibodies, to the
prevalence of the virus in humans. That may be why glycosite 365
on NA was replaced by glycosite 434 in 1986–1987.
The amino acid variability analysis showed that after glycans
were located at glycosite 365 (1936–1984), the amino acid
variation at antigenic sites 3 and 5 continually decreased
Figure 2. Amino acid variability at antigenic sites of HA (A) and NA (B) in human seasonal influenza H1N1 viruses. The variability was
the total number of amino acids present at each antigenic region in the group of isolates with specific glycosite pattern. The numbers of
corresponding strains in each group used for the analysis are given in the brackets.
doi:10.1371/journal.pone.0032119.g002
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also decreased during 1933–1979 (Figure 2b), it dramatically
increased in the time periods of 1981–1984, which might mean
that the immune pressures imposed at this site by host were rising.
The glycosite migration to this antigenic site (glycosite 434 on NA)
might just to meet the need of resistance against these immune
pressures for influenza H1N1 viruses.
Glycosite migrations in the stalk regions of NA
Two glycosite migration (site 50 to 44 in 1947, and site 68 to 79
in 1980) occurred in the NA stalk region of the human seasonal
influenza H1N1 viruses [25]. The stalk region of NA is probably
the most exposed and vulnerable region to protease attacks, as NA
is frequently released from viral particles through proteolytic
cleavage of this region [22,33,34,35]. Our research showed that
the NA of the seasonal influenza viruses generally had two or three
tryptic cleavage sites, but there was none existed in 1918 viruses
and only one (which is also different from those in seasonal viruses)
existed in pandemic 2009 viruses(Table S4). The glycans at all
glycosites in the NA stalk region as well as at glycosite 235 on the
head of NA (this site is near the enzymatic cleavage site between
the stalk and the head of NA. Data was not shown) might be
involved in the protection of viral NA against the host proteases.
However, the glycans at glycosites 44 and 70 may be more
effective than glycosites 50 and 68 in protecting the NA stalk
against the host proteases, and thus glycosite migrations occurred
at these sites.
Discussion
In this study, homology modeling and in silico protein
glycosylation of representative HA and NA proteins as well as
amino acid variability analysis at antigenic sites were employed for
predicting biological functions of glycosite migrations in the host
adaptation of human seasonal influenza H1N1 viruses. After
modeling the structures of representative HA and NA proteins
(including their different patterns of potential N-glycosites) from
human influenza A (H1N1) viruses, complex glycans lacking
terminal sialic acid residues were added in silico onto each variable
glycosite using the Glyprot server. The structure of the glycans
attached to each site may differ since glycan structure on HA and
NA is mainly determined by the host and by the location of the
glycosite for influenza viruses. Mammalian cells possess a great
deal of glycosylating enzymes and thus generally add large, tri- and
tetra-antennary oligosaccharides onto the HA and NA of influenza
viruses [8,36]. Here, these glycans only consisted of nine
monosaccharides without terminal sialic acid residues were used
in this study, which should be suitable to model the natural state of
the viral glycans as far as possible for a fair prediction of the
possible function of the glycans attached at various important
glycosites.
In influenza H1N1 viruses, some of the potential glycosites, such
as glycosites 28, 40, 104, 304, 498 and 557 on HA and glycosites
58, 63, 88, 146 and 235 on NA, were highly conserved in all
strains isolated from various animals and humans and therefore
appeared to be essential for the formation and/or maintenance of
functional HA and NA. While some other glycosites, such as
glycosites 142, 144, 172, 177 and 179 on the top of the HA head,
glycosites 71 and 286 on the side of the HA head and glycosites
365, 434 and 455 around the enzymatic active centre of NA, only
appeared during certain evolutionary periods for the human
seasonal influenza H1N1 viruses [25]. Glycosylation at any one of
these sites is neither prohibited nor required for the formation of
the functional HA, glycan diversity might have a major selective
effect for function of the HA. The presence or absence, the
location and the structures of the glycans for those variable sites
could determine how well the virus grows in certain species of cells.
It has been proven that the acquisition of potential glycosylation
sites is one of the effective ways for influenza viruses to escape
positive selective pressures from the hosts [7,8]. Here, several
possible biological functions of glycosite migration for the host
adaptation of human seasonal influenza H1N1 viruses were
summarized as below based on the analysis above:
The first possible biological function of glycosite migrations is to
more effectively mask the antigenic sites of HA and NA, which is
very important for viral immune evasion from host. Some new
glycosites were added to mask antigenic sites, while some
positional conversions of the glycosites were mainly to increase
the effectiveness with which the glycan masks the antigenic sites.
For example, the glycans attached to glycosites 144 and 179 of HA
could mask the HA antigenic site Sa, however, the glycans
attached to glycosites 172, 142 and 177 of HA might be more
effective to mask it.
The second possible biological function is to more effectively
protect the enzymatic cleavage sites of NA. One possible function
of the glycans attached to the glycosites on the stalk of NA and to
glycosite 235 is to protect the enzymatic cleavage sites on the stalk.
The positional conversion of the glycosites on the stalk of NA (such
Figure 3. Structural overviews of the glycans attached to glycosites 144 (A), 172 (B) and 142 (C) and their shielding regions on HA
of human seasonal influenza H1N1 viruses. The glycosites are numbered in white.
doi:10.1371/journal.pone.0032119.g003
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more effectively protect the enzymatic cleavage sites on the stalk of
NA.
The third possible biological function is to stabilize the
structures of the polymeric glycoproteins. The addition or
positional conversion of glycosites to the subunit interfaces of
HA and NA may function to stabilize the trimeric structures of HA
and NA, respectively. This could be the case for the glycans
attached to glycosites 179, 177, 71 and 104 of HA and to glycosites
146, 434 and 455 of NA. For example, twelve glycans attached at
glycosites 146, 434 and 455 on each tetrameric NA (1986–2009
strains) could cover almost all of the interfaces between subunits of
the NA, which should efficiently enhance the stability of the NA
(Figure 5a).
The fourth possible biological function is to regulate the activity
of HA and NA. The positional conversion of glycosite 179 to
glycosite 177 on HA might effectively reduce the obstruction of the
receptor binding sites on the neighboring subunit and thus
increase the receptor binding activity of HA. The positional
conversion of glycosite 104 to glycosite 71 on HA could also
effectively reduce the obstruction of the receptor binding site.
Glycosites 146, 365 and 434 were located around the enzymatic
active site, and therefore the glycans attached to these sites may
regulate the catalytic activity of NA.
The fifth possible biological function is to balance the binding
activity of HA with the releasing activity of NA. In fact, HA and
NA together determine the traits of the influenza viruses, such as
the host range, virulence and infectivity. It is necessary for the
Figure 4. Structural overviews of the glycans attached to glycosites 104 (A), 286 (B) and 71 (C) and their shielding regions on HA of
human seasonal influenza H1N1 viruses. The glycosites are numbered in white.
doi:10.1371/journal.pone.0032119.g004
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with the releasing activity of NA in the viral life cycle, and glycosite
number was one of the important mediation factors by mediating
their proper steric structures, influencing their activity and
promoting the infection and spread of the influenza virus.
[37,38,39]. If the binding strength between the host receptor
and HA increases when HA has fewer carbohydrate modifications,
then the activity of NA must also increase in order to promote the
release of the viral particle from the surface of the host cell.
Conversely, when HA is extensively glycosylated, it may interact
weakly with the host receptors. At this time, the influenza virus
would require a less active NA to facilitate the release of the viral
particle. Moreover, it has been reported that the HA and NA of
the pandemic 1918 and 2009 influenza viruses need to be correctly
paired (HA 1918+NA 1918, HA 2009+NA 2009) to achieve the
highest infectious activity [40]. The glycosite migration should
have the same functions in the activity mediation of HA and NA as
glycosite numbers. The nearly identical evolutionary process and
phases of glycosites on both HA and NA proteins described
previously (glycosite addition or migration occurred on both HA
and NA almost synchronously) could account for the requirement
of corresponding matching patterns of glycosylation on the HA
and NA of influenza viruses (Figure S1) [25].
Besides, glycosite migrations may also play an important role in
coordinating the function of the glycans at different glycosites.
When one glycan can shield an antigenic site or enzymatic
cleavage site effectively after it transfers from one glycosite to
another, some of the other glycans may also need to transfer for
protecting other regions. This may happen between the positional
conversions of glycosite 179 to 177 and glycosite 144 to 172 and
then to 142. When antigenic Sb site of HA can be protected well
by glycans at glycosite 177 on the adjacent subunit, the glycans at
glycosite 144 may need to transfer to site 172 and then to site 142
to shield antigenic Sa site more effectively.
Since the addition of glycans around the receptor binding site of
HA and the enzymatic active centre of NA can have either positive
or detrimental effects on the virus–while it shields antigenic sites
against immune recognition, it reduces receptor affinity of HA and
enzymatic activity of NA [8,15], glycosite migration (with no
glycan added) may be one of the artful manners for human
seasonal influenza viruses to maximize the ratio of positive to
detrimental effects of each added glycan.
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Figure S1 Coordination of glycosite alterations between
HA and NA of human seasonal influenza H1N1 viruses
Figure 5. Structural overviews of the glycosylated tetramer from A/Singapore/6/1986 (A) and the shielding regions of the glycans
attached to glycosites in region C, including glycosites 146 (B), 365 (C) and 434 (D). The glycosites are numbered in white.
doi:10.1371/journal.pone.0032119.g005
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alteration process of glycosites on the head of NA. (D) The
alteration process of glycosites on the stalk of NA. The dotted lines
represented the superficial alterations based on genome-based
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(DOC)
Author Contributions
Conceived and designed the experiments: SS QW ZL. Performed the
experiments: SS QW. Analyzed the data: SS QW FZ WC ZL. Contributed
reagents/materials/analysis tools: SS QW WC ZL. Wrote the paper: SS
QW FZ WC ZL. Designed the program used in analysis: QW SS ZL.
References
1. Neumann G, Noda T, Kawaoka Y (2009) Emergence and pandemic potential of
swine-origin H1N1 influenza virus. Nature 459: 931–939.
2. Kilbourne ED (2006) Influenza pandemics of the 20th century. Emerg Infect Dis
12: 9–14.
3. Lin T, Wang G, Li A, Zhang Q, Wu C, et al. (2009) The hemagglutinin
structure of an avian H1N1 influenza A virus. Virology 392: 73–81.
4. Shi W, Lei F, Zhu C, Sievers F, Higgins DG (2010) A Complete Analysis of HA
and NA Genes of Influenza A Viruses. PLOS One 5: e14454.
5. Wei CJ, Boyington JC, Dai K, Houser KV, Pearce MB, et al. (2010) Cross-
neutralization of 1918 and 2009 influenza viruses: role of glycans in viral
evolution and vaccine design. Sci Transl Med 2: 24ra21.
6. Zhang M, Gaschen B, Blay W, Foley B, Haigwood N, et al. (2004) Tracking
global patterns of N-linked glycosylation site variation in highly variable viral
glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin.
Glycobiology 14: 1229–1246.
7. Vigerust DJ, Shepherd VL (2007) Virus glycosylation: role in virulence and
immune interactions. TRENDS Microbiol 15: 211–218.
8. Schulze IT (1997) Effects of glycosylation on the properties and functions of
influenza virus hemagglutinin. J Infect Dis 176(Suppl 1): S24–28.
9. Gambaryan AS, Marinina VP, Tuzikov AB, Bovin NV, Rudneva IA, et al.
(1998) Effects of host-dependent glycosylation of hemagglutinin on receptor-
binding properties of H1N1 human influenza A virus grown in MDCK cells and
in embryonated eggs. Virology 247: 170–177.
10. Gao Y, Zhang Y, Shinya K, Deng G, Jiang Y, et al. (2009) Identification of
amino acids in HA and PB2 critical for the transmission of H5N1 avian
influenza viruses in a mammalian host. PLoS Pathog 5: e1000709.
11. Matrosovich M, Zhou N, Kawaoka Y, Webster R (1999) The surface
glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild
aquatic birds have distinguishable properties. J Virol 73: 1146–1155.
12. Ohuchi M, Ohuchi R, Feldmann A, Klenk H (1997) Regulation of receptor
binding affinity of influenza virus hemagglutinin by its carbohydrate moiety.
J Virol 71: 8377–8384.
13. Mishin VP, Novikov D, Hayden FG, Gubareva LV (2005) Effect of
hemagglutinin glycosylation on influenza virus susceptibility to neuraminidase
inhibitors. J Virol 79: 12416–12424.
14. Skehel JJ, Stevens DJ, Daniels RS, Douglas AR, Knossow M, et al. (1984) A
carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses
inhibits recognition by a monoclonal antibody. PNAS 81: 1779–1783.
15. Abe Y, Takashita E, Sugawara K, Matsuzaki Y, Muraki Y, et al. (2004) Effect of
the addition of oligosaccharides on the biological activities and antigenicity of
influenza A/H3N2 virus hemagglutinin. J Virol 78: 9605–9611.
16. Munk K, Pritzer E, Kretzschmar E, Gutte B, Garten W, et al. (1992)
Carbohydrate masking of an antigenic epitope of influenza virus haemagglutinin
independent of oligosaccharide size. Glycobiology 2: 233–240.
17. Deshpande KL, Fried VA, Ando M, Webster RG (1987) Glycosylation affects
cleavage of an H5N2 influenza virus hemagglutinin and regulates virulence.
PNAS 84: 36–40.
18. Ohuchi M, Orlich M, Ohuchi R, Simpson BEJ, Garten W, et al. (1989)
Mutations at the cleavage site of the hemagglutinin alter the pathogenicity of
influenza virus a/chick/penn/83 (H5N2). Virology 168: 274–280.
19. Bosch FX, Garten W, Klenk HD, Rott R (1981) Proteolytic cleavage of
influenza virus hemagglutinins: primary structure of the connecting peptide
between HA1 and HA2 determines proteolytic cleavability and pathogenicity of
avian influenza viruses. Virology 113: 725–735.
20. Matsuoka Y, Swayne DE, Thomas C, Rameix-Welti MA, Naffakh N, et al.
(2009) Neuraminidase stalk length and additional glycosylation of the
hemagglutinin influence the virulence of influenza H5N1 viruses for mice.
J Virol 83: 4704–4708.
21. Stevens J, Corper AL, Basler CF, Taubenberger JK, Palese P, et al. (2004)
Structure of the uncleaved human H1 hemagglutinin from the extinct 1918
influenza virus. Science 303: 1866–1870.
22. Wu ZL, Ethen C, Hickey GE, Jiang W (2009) Active 1918 pandemic flu viral
neuraminidase has distinct N-glycan profile and is resistant to trypsin digestion.
Biochem Bioph Res Co 379: 749–753.
23. Igarashi M, Ito K, Kida H, Takada A (2008) Genetically destined potentials for
N-linked glycosylation of influenza virus hemagglutinin. Virology 376: 323–329.
24. Das SR, Puigbo P, Hensley SE, Hurt DE, Bennink JR, et al. (2010)
Glycosylation Focuses Sequence Variation in the Influenza A Virus H1
Hemagglutinin Globular Domain. PLoS Pathog 6: e1001211.
25. Sun S, Wang Q, Zhao F, Chen W, Li Z (2011) Glycosylation site alteration in
the evolution of influenza A (H1N1) viruses. PLOS One 6: e22844.
26. Chang S, Zhang J, Liao X, Zhu X, Wang D, et al. (2007) Influenza Virus
Database (IVDB): an integrated information resource and analysis platform for
influenza virus research. Nucleic Acids Res 35: D376–D380.
27. Bao Y, Bolotov P, Dernovoy D, Kiryutin B, Zaslavsky L, et al. (2008) The
influenza virus resource at the national center for biotechnology information.
J Virol 82: 596–601.
28. Arnold K, Bordoli L, Kopp J, Schwede T (2006) The SWISS-MODEL
workspace: A web-based environment for protein structure homology modelling.
Bioinformatics 22: 195–201.
29. Bohne-Lang A, Lieth C-Wvd (2005) GlyProt: in silico glycosylation of proteins.
Nucleic Acids Res 33(suppl 2): W214–W219.
30. DeLano WL (2002) Pymol: An open-source molecular graphics tool. http://
www.pymol.org/.
31. Hay AJ, Gregory V, Douglas AR, Lin YP (2001) The evolution of human
influenza viruses. Philos T R Soc B 356: 1861–1870.
32. Gamblin SJ, Haire LF, Russell RJ, Stevens DJ, Xiao B, et al. (2004) The
structure and receptor binding properties of the 1918 influenza hemagglutinin.
Science 303: 1838–1842.
33. Russell RJ, Haire LF, Stevens DJ, Collins PJ, Lin YP, et al. (2006) The structure
of H5N1 avian influenza neuraminidase suggests new opportunities for drug
design. Nature 443: 45–49.
34. Varghese JN, Laver WG, Colman PM (1983) Structure of the influenza virus
glycoprotein antigen neuraminidase at 2.9 A ˚ resolution. Nature 303.
35. Colman PM, Varghese JN, Laver WG (1983) Structure of the catalytic and
antigenic sites in influenza virus neuraminidase. Nature 303: 41–44.
36. Mir-Shekari SY, Ashford DA, Harvey DJ, Dwek RA, Schulze IT (1997) The
glycosylation of the influenza A virus hemagglutinin by mammalian cells-a site-
specific study. J Biol Chem 272: 4027–4036.
Functions of Glycosylation Site Migrations
PLoS ONE | www.plosone.org 7 February 2012 | Volume 7 | Issue 2 | e3211937. Baigent SJ, McCauley JW (2001) Glycosylation of haemagglutinin and stalk-
length of neuraminidase combine to regulate the growth of avian influenza
viruses in tissue culture. Virus Res 79: 177–185.
38. Wagner R, Wolff T, Herwig A, Pleschka S, Klenk HD (2000) Interdependence
of hemagglutinin glycosylation and neuraminidase as regulators of influenza
virus growth: a study by reverse genetics. J Virol 74: 6316–6323.
39. Mitnaul LJ, Matrosovich MN, Castrucci MR, Tuzikov AB, Bovin NV, et al.
(2000) Balanced hemagglutinin and neuraminidase activities are critical for
efficient replication of influenza A virus. J Virol 74: 6015–6020.
40. Zhang Y, Lin X, Zhang F, Wu J, Tan W, et al. (2009) Hemagglutinin and
neuraminidase matching patterns of two influenza A virus strains related to the
1918 and 2009 global pandemics. Biochem BiophRes Co 387: 405–408.
Functions of Glycosylation Site Migrations
PLoS ONE | www.plosone.org 8 February 2012 | Volume 7 | Issue 2 | e32119